Hangzhou, China

Anhua Lei

This inventor holds 2 USPTO granted patents. Top assignee: Zhejiang University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anhua Lei. Retrieved from https://idiyas.com/inventor/anhua-lei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anhua Lei: Innovator in Macrophage Research

Introduction

Anhua Lei is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of immunology, particularly in the development of innovative therapies involving macrophages. His work is recognized for its potential to advance medical treatments and improve patient outcomes.

Latest Patents

Anhua Lei holds a patent for a "Chimeric Antigen Receptor, Macrophage Expressing Same, Method for Adjusting Macrophage Polarization, and Use Thereof." This patent highlights his innovative approach to manipulating macrophage behavior, which could have far-reaching implications in cancer therapy and other diseases.

Career Highlights

Anhua Lei is affiliated with Zhejiang University, where he conducts research and collaborates with other experts in the field. His academic background and research focus have positioned him as a key figure in the study of macrophage biology and its applications in medicine.

Collaborations

Anhua Lei has worked alongside notable colleagues, including Jin Zhang and Lin Tian. Their collaborative efforts have contributed to the advancement of research in macrophage polarization and its therapeutic uses.

Conclusion

Anhua Lei's innovative work in macrophage research and his patent contributions underscore his role as a leading inventor in the field. His research has the potential to pave the way for new therapeutic strategies in immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…